418 related articles for article (PubMed ID: 16823825)
21. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
Nakamura S
Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
[TBL] [Abstract][Full Text] [Related]
22. [Incidence and histologic patterns of bone marrow involvement of malignant lymphoma based on the World Health Organization classification: a single institution study].
Jeong SY; Chang YH; Lee JK; Hong YJ; Hong SI; Lee SS
Korean J Lab Med; 2007 Dec; 27(6):383-7. PubMed ID: 18160826
[TBL] [Abstract][Full Text] [Related]
23. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas.
Chuang SS; Chang ST; Chuang WY; Huang WT; Hsieh PP; Tsou MH; Liao YL; Lin SH; Hsieh YC; Lu CL; Sheu MJ; Liu H
Am J Surg Pathol; 2009 Aug; 33(8):1230-40. PubMed ID: 19561449
[TBL] [Abstract][Full Text] [Related]
24. [The WHO (1997) classification of 370 cases of malignant lymphomas].
He S; Zhang JB; Zhang JG; Yang SY; Han F
Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):519-22. PubMed ID: 14690580
[TBL] [Abstract][Full Text] [Related]
25. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
28. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
29. [Significance of typing in the survival of malignant lymphomas].
Su ZL
Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):186-9. PubMed ID: 1396057
[TBL] [Abstract][Full Text] [Related]
30. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
31. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
Yeh KH; Cheng AL; Su IJ; Lin MT; Tien HF; Shen MC; Wang CH; Chen YC
Anticancer Res; 1997; 17(3C):2269-72. PubMed ID: 9216700
[TBL] [Abstract][Full Text] [Related]
33. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
34. Value of ultrasound-guided core biopsy in the diagnosis of malignant lymphoma.
de Larrinoa AF; del Cura J; Zabala R; Fuertes E; Bilbao F; Lopez JI
J Clin Ultrasound; 2007; 35(6):295-301. PubMed ID: 17486566
[TBL] [Abstract][Full Text] [Related]
35. Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification.
Chinen K; Izumo T
Ann Hematol; 2005 Aug; 84(8):498-505. PubMed ID: 15782345
[TBL] [Abstract][Full Text] [Related]
36. Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.
Yaqo RT; Hughson MD; Sulayvani FK; Al-Allawi NA
Indian J Cancer; 2011; 48(4):446-51. PubMed ID: 22293258
[TBL] [Abstract][Full Text] [Related]
37. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
38. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
39. [Primary breast lymphoma--a report of 27 cases with literature review].
Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal lymphomas of T- and B-cell types.
Isaacson PG
Mod Pathol; 1999 Feb; 12(2):151-8. PubMed ID: 10071340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
